Evidence map›Paper›PMID 40853686›Full record

ReviewFEMS yeast research2025

Perspectives on current and future yeast technologies for ethanol-based biofuels and bioproducts.

Paul V Attfield, Kelly Boyd, Dragana Purkovic, Woon Siew Ng, Psyche Arcenal, Heinrich Kroukamp, Philip J L Bell

Abstract readReview
In one paragraph

Review in FEMS yeast research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul V AttfieldMicrobiogen Pty Ltd., Macquarie Park, NSW 2113, Australia.ORCID 0000-0003-0862-2384
Kelly BoydMicrobiogen Pty Ltd., Macquarie Park, NSW 2113, Australia.
Dragana PurkovicMicrobiogen Pty Ltd., Macquarie Park, NSW 2113, Australia.
Woon Siew NgMicrobiogen Pty Ltd., Macquarie Park, NSW 2113, Australia.
Psyche ArcenalMicrobiogen Pty Ltd., Macquarie Park, NSW 2113, Australia.
Heinrich KroukampMicrobiogen Pty Ltd., Macquarie Park, NSW 2113, Australia.
Philip J L BellMicrobiogen Pty Ltd., Macquarie Park, NSW 2113, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Greenhouse gases drive climate change, which leads to less productive farmland and diminishing food security. Fossil oil, which is used for transport fuels and for manufacturing plastics, synthetic fabrics and other everyday products, is a major contributor to climate change. Significant greenhouse gas abatement can be achieved by replacing fossil oil with renewable biofuels. Bioethanol is proven as a road transport fuel and has potential to be converted into sustainable aviation fuel and chemicals currently made from oil. First-generation (1G) bioethanol is produced by yeast fermentation of six-carbon sugars from food crops, and it represents the major biofuel by volume. A growing second-generation (2G) industry produces bioethanol via yeast fermentation of six- and five-carbon lignocellulosic sugars. This article considers yeast-dependent aspects of 1G and 2G technologies. Critical phenotypes essential for bioethanol processes are reviewed along with classical and molecular genetic strategies for yeast strain improvements. Bioethanol production needs to be increased substantially to approach full fossil oil replacement. The future for bioethanol and the role of yeasts in mitigating climate change and improving land-use are discussed in terms of third- and fourth-generation bioethanol, and multiproduct Power-to-X biorefineries that include potential for carbon dioxide fixation by yeasts.

Indexed as

BiofuelsBiotechnologyEthanolSaccharomyces cerevisiaeYeastsFermentationBiofuelsEthanolbioethanolclassical geneticsclimate changegreenhouse gas abatementlignocellulosicsmolecular and synthetic biologystress responseyeast

Identifiers

PMID40853686
PMCPMC12416288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.